In addition to the monetary settlement, Stryker has agreed to establish a committee tasked with preventing violations of the False Claims Act and the Foreign Corrupt Practices Act. The shareholder lawsuit stems from previous legal troubles, including Stryker’s recalled Trident hip implant and alleged illegal cross-labeling promotion of a bone putty product.
More Articles on Orthopedic Devices:
Houston Orthopedic and Spine Hospital Now Has Robotic Spine Surgery
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
Biomet Announces European Launch of Comprehensive Shoulder Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.